Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency
14/08/2026 06:01
BRIEF-Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency Aug 14 (Reuters) - Pfizer PFE.N:
PFIZER AND VALNEVA’S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
: PFIZER AND VALNEVA'S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
Source text: ID:nGNXbcryXk
Further company coverage: VLS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsFactbox: Pharma sector doubles down on AI to slash costs, timelines
Focus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Eli Lilly hits record high as healthcare stocks rally
Factbox: Pharma sector doubles down on AI to slash costs, timelines
Factbox: Major drugmakers turn to China for licensing deals